Lenalidomide capsules (Revlimid®) accepted for use within NHSScotland as maintenance treatment of newly diagnosed multiple myeloma

In phase III, randomised studies, lenalidomide maintenance treatment improved progression-free survival in patients who had undergone autologous stem cell transplantation vs placebo/observation. Median overall survival data were supportive of lenalidomide maintenance treatment.

Scottish Medicines Consortium